Beneficient Receives Additional Nasdaq Listing Determination

About this update from Beneficient

[{"type":"image","alt":"Beneficient","displaySize":"","headline":null,"caption":"Beneficient","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":91,"url":"https://media.zenfs.com/en/globenewswire.com/6254ab78e0146105512f41e7220c340a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Hfsww4YklfCjXvUIHzrfUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/6254ab78e0146105512f41e7220c340a","width":300,"height":91}},"lazy":false},{"type":"text","content":"DALLAS, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that on August 18, 2025, the Company was notified by The Nasdaq Stock Market LLC (“Nasdaq”) that, the delay in the filing of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 with the Securities and Exchange Commission (the “SEC”), in contravention of Nasdaq’s periodic reporting requirement set forth in Nasdaq Listing Rule 5250(c)(1), served as an additional basis for delisting from The Nasdaq Capital Market.","length":756,"tagName":"p"},{"type":"text","content":"As previously disclosed, the Company previously received a notification from Nasdaq that due to its continued non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) and the delay in the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2025 with the SEC in contravention of Nasdaq’s periodic reporting requirement set forth in Nasdaq Listing Rule 5250(c)(1), the Company’s securities were subject to delisting.","length":496,"tagName":"p"},{"type":"text","content":"The Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”), at which the Company will present its plan to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market and request an extension of time to do so. While the Company is taking definitive steps to evidence compliance with the applicable listing criteria as soon as practicable, there can be no assurance that the Panel will grant the Company’s request for continued l...

More updates from Beneficient